124 related articles for article (PubMed ID: 31449595)
1. Patient with a PRKAG2 mutation who developed Immunoglobulin A nephropathy: a case report.
Giudici MC; Ahmad F; Holanda DG
Eur Heart J Case Rep; 2019 Jun; 3(2):. PubMed ID: 31449595
[TBL] [Abstract][Full Text] [Related]
2. Intrafamilial Phenotypical Variability Linked to PRKAG2 Mutation-Family Case Report and Review of the Literature.
Marcu AS; Vătăşescu R; Onciul S; Rădoi V; Jurcuţ R
Life (Basel); 2022 Dec; 12(12):. PubMed ID: 36556501
[TBL] [Abstract][Full Text] [Related]
3. Ventricular pre-excitation and cardiac hypertrophy mimicking hypertrophic cardiomyopathy in a Turkish family with a novel PRKAG2 mutation.
Bayrak F; Komurcu-Bayrak E; Mutlu B; Kahveci G; Basaran Y; Erginel-Unaltuna N
Eur J Heart Fail; 2006 Nov; 8(7):712-5. PubMed ID: 16716659
[TBL] [Abstract][Full Text] [Related]
4. PRKAG2 mutations presenting in infancy.
Torok RD; Austin SL; Phornphutkul C; Rotondo KM; Bali D; Tatum GH; Wechsler SB; Buckley AF; Kishnani PS
J Inherit Metab Dis; 2017 Nov; 40(6):823-830. PubMed ID: 28801758
[TBL] [Abstract][Full Text] [Related]
5. Novel PRKAG2 variant presenting as liver cirrhosis: report of a family with 2 cases and review of literature.
Beyzaei Z; Ezgu F; Geramizadeh B; Alborzi A; Shojazadeh A
BMC Med Genomics; 2021 Jan; 14(1):33. PubMed ID: 33509202
[TBL] [Abstract][Full Text] [Related]
6. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy.
Gollob MH; Seger JJ; Gollob TN; Tapscott T; Gonzales O; Bachinski L; Roberts R
Circulation; 2001 Dec; 104(25):3030-3. PubMed ID: 11748095
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel de novo mutation associated with PRKAG2 cardiac syndrome and early onset of heart failure.
Liu Y; Bai R; Wang L; Zhang C; Zhao R; Wan D; Chen X; Caceres G; Barr D; Barajas-Martinez H; Antzelevitch C; Hu D
PLoS One; 2013; 8(5):e64603. PubMed ID: 23741347
[TBL] [Abstract][Full Text] [Related]
8. A novel PRKAG2 mutation in a Chinese family with cardiac hypertrophy and ventricular pre-excitation.
Yang KQ; Lu CX; Zhang Y; Yang YK; Li JC; Lan T; Meng X; Fan P; Tian T; Wang LP; Liu YX; Zhang X; Zhou XL
Sci Rep; 2017 May; 7(1):2407. PubMed ID: 28546535
[TBL] [Abstract][Full Text] [Related]
9. Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency.
Burwinkel B; Scott JW; Bührer C; van Landeghem FK; Cox GF; Wilson CJ; Grahame Hardie D; Kilimann MW
Am J Hum Genet; 2005 Jun; 76(6):1034-49. PubMed ID: 15877279
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic analysis of PRKAG2 in sporadic Wolff-Parkinson-White syndrome.
Vaughan CJ; Hom Y; Okin DA; McDermott DA; Lerman BB; Basson CT
J Cardiovasc Electrophysiol; 2003 Mar; 14(3):263-8. PubMed ID: 12716108
[TBL] [Abstract][Full Text] [Related]
11. [Same genotype and different phenotypes in a family with PRKAG2 gene mutation].
Hong K; Oliva A; Cheng XS; Brugada P; Brugada J; Sternick EB; Brugada R
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):552-4. PubMed ID: 17711718
[TBL] [Abstract][Full Text] [Related]
12. Novel PRKAG2 Variant Manifesting with a Cardiac Arrest in a Child.
Spentzou G; McGowan R; Hares D; McLeod K
Pediatr Cardiol; 2020 Apr; 41(4):843-845. PubMed ID: 31720784
[TBL] [Abstract][Full Text] [Related]
13. Functional Prediction of Chronic Kidney Disease Susceptibility Gene PRKAG2 by Comprehensively Bioinformatics Analysis.
Wang E; Zhao H; Zhao D; Li L; Du L
Front Genet; 2018; 9():573. PubMed ID: 30559760
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a PRKAG2 cardiac syndrome disease model and mechanism study using human induced pluripotent stem cells.
Zhan Y; Sun X; Li B; Cai H; Xu C; Liang Q; Lu C; Qian R; Chen S; Yin L; Sheng W; Huang G; Sun A; Ge J; Sun N
J Mol Cell Cardiol; 2018 Apr; 117():49-61. PubMed ID: 29452156
[TBL] [Abstract][Full Text] [Related]
15. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.
Arad M; Benson DW; Perez-Atayde AR; McKenna WJ; Sparks EA; Kanter RJ; McGarry K; Seidman JG; Seidman CE
J Clin Invest; 2002 Feb; 109(3):357-62. PubMed ID: 11827995
[TBL] [Abstract][Full Text] [Related]
16. Atrial Flutter in PRKAG2 Syndrome: Clinical and Electrophysiological Characteristics.
Magalhães EFS; Magalhães LP; Pinheiro JO; Guabiru AT; Aras R
Arq Bras Cardiol; 2022 Sep; 119(5):681-8. PubMed ID: 36102422
[TBL] [Abstract][Full Text] [Related]
17. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
Arad M; Maron BJ; Gorham JM; Johnson WH; Saul JP; Perez-Atayde AR; Spirito P; Wright GB; Kanter RJ; Seidman CE; Seidman JG
N Engl J Med; 2005 Jan; 352(4):362-72. PubMed ID: 15673802
[TBL] [Abstract][Full Text] [Related]
18. CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities.
Ben Jehuda R; Eisen B; Shemer Y; Mekies LN; Szantai A; Reiter I; Cui H; Guan K; Haron-Khun S; Freimark D; Sperling SR; Gherghiceanu M; Arad M; Binah O
Heart Rhythm; 2018 Feb; 15(2):267-276. PubMed ID: 28917552
[TBL] [Abstract][Full Text] [Related]
19. Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history.
Murphy RT; Mogensen J; McGarry K; Bahl A; Evans A; Osman E; Syrris P; Gorman G; Farrell M; Holton JL; Hanna MG; Hughes S; Elliott PM; Macrae CA; McKenna WJ
J Am Coll Cardiol; 2005 Mar; 45(6):922-30. PubMed ID: 15766830
[TBL] [Abstract][Full Text] [Related]
20. Increased alpha2 subunit-associated AMPK activity and PRKAG2 cardiomyopathy.
Ahmad F; Arad M; Musi N; He H; Wolf C; Branco D; Perez-Atayde AR; Stapleton D; Bali D; Xing Y; Tian R; Goodyear LJ; Berul CI; Ingwall JS; Seidman CE; Seidman JG
Circulation; 2005 Nov; 112(20):3140-8. PubMed ID: 16275868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
